A Pharmacoeconomic Analysis of Rimelolone for the Treatment of Ophthalmic Inflammatory Conditions

June 1, 1998

Michael T. Halpern, MD, PhD

Michael T. Halpern, MD, PhD

, Cynthia S. Palmer, MSc

Cynthia S. Palmer, MSc

, C. Stephen Foster, MD

C. Stephen Foster, MD

, Ashish Pal, BS Pharm, MBA

Ashish Pal, BS Pharm, MBA

, Carmelina Battista, PharmD

Carmelina Battista, PharmD

Volume 4, Issue 6